ENDRA Life Sciences Expands IP Portfolio to 72 with Addition of Key Patents

Tailwinds' Take: Good news but we are still awaiting the bigger catalysts of an FDA filing here in Q2 and EU launch later this...

ENDRA Life Sciences Announces New Clinical Study Partnership with the Medical College of Wisconsin...

Tailwinds' Take: Medical College of Wisconsin is a leading institution and this should bring more interest to TAEUS as rollout of the product starts...

Revisiting Endra…Has Their Time Arrived?

About two years ago, I covered and owned shares of Endra (NDRA). The investment thesis centered around their innovative platform which incorporates radio frequency...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.